In addition, CEF administration to animal models of Alzheimer's disease displayed an upregulation of GLT-1 expression, preservation of synaptic proteins and downregulation of tau proteins (Zumkehr et al., 2015). This evidence concerns the gene SLC1A2 and Alzheimer disease.